High expression of Zinc-binding protein-89 predicts decreased survival in esophageal squamous cell cancer

Annals of Thoracic Surgery

Volumn 97, Issue 6, 2014, Pages 1966-1973

  Yan, Shu Mei ^a   Wu, Hui Ni ^b   He, Fan ^c   Hu, Xiao Peng ^b   Zhang, Zhi Yi ^a   Huang, Ma Yan ^a   Wu, Xiao ^d   Huang, Chun Yu ^a   Li, Yong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; ZINC BINDING PROTEIN; ZINC BINDING PROTEIN 89;

ADULT; ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TRANSCRIPTION FACTORS;

EID: 84901769564     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.01.058     Document Type: Article

References (24)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA: Cancer J Clin 55 2005 74 108
2. W.J. Blot, J.K. McLaughlin, and J.F. Fraumeni Jr. Esophageal cancer D. Schottenfeld, J.F. Fraumeni Jr. Cancer epidemiology and prevention III ed. 2006 Oxford University Press New York 697 706
3. L. Tong, S. Yuan, F. Feng, and H. Zhang Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study Dis Esophagus 25 2012 72 80
4. A.P. Polednak Trends in survival for both histologic types of esophageal cancer in us surveillance, epidemiology and end results areas Int J Cancer 105 2003 98 100
5. K. Mealy, J. Feely, I. Reid, J. McSweeney, T. Walsh, and T.P. Hennessey Tumour marker detection in oesophageal carcinoma Eur J Surg Oncol 22 1996 505 507
6. L. Bai, S.O. Yoon, P.D. King, and J.L. Merchant ZBP-89-induced apoptosis is p53-independent and requires JNK Cell Death Differ 11 2004 663 673
7. M. Salmon, and Z.E. Zehner The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesis Differentiation 77 2009 492 504
8. L. Bai, C. Logsdon, and J.L. Merchant Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer Int J Gastrointest Cancer 31 2002 79 88
9. M.I. Dawson, J.H. Park, and G. Chen et al. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O- tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition Int J Cancer 91 2001 8 21
10. P.Y. Cheng, N. Kagawa, Y. Takahashi, and M.R. Waterman Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription Biochemistry 39 2000 4347-7
11. A.C. Keates, S. Keates, and J.H. Kwon et al. ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells J Biol Chem 276 2001 43713 43722
12. L. Bai, and J.L. Merchant Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells J Biol Chem 275 2000 30725 30733
13. T. Taniuchi, E.R. Mortensen, A. Ferguson, J. Greenson, and J.L. Merchant Overexpression of ZBP-89, a zinc finger DNA binding protein, in gastric cancer Biochem Biophys Res Commun 233 1997 154 160
14. C.Z. Zhang, Y. Cao, J.P. Yun, G.G. Chen, and P.B. Lai Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma Histopathology 60 2012 1114 1124
15. A. Morán, P. Iniesta, C. de Juan, C. García-Aranda, A. Díaz-López, and M. Benito Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors Cancer Res 65 2005 3811 3814
16. T. Frensing, C. Kaltschmidt, and T. Schmitt-John Characterization of a neuregulin-1 gene promoter: positive regulation of type I isoforms by NF-kappaB Biochim Biophys Acta 1779 2008 139 144
17. M.Y. Cai, R.Z. Luo, and Y.H. Li et al. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma Biochem Biophys Res Commun 426 2012 636 642
18. L. Bai, and J.L. Merchant ZBP-89 promotes growth arrest through stabilization of p53 Mol Cell Biol 21 2001 4670 4683
19. G.G. Chen, J.L. Merchant, and P.B. Lai et al. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89 Am J Pathol 162 2003 1823 1829
20. D. Tvrdík, P. Dundr, C. Povýsil, R. Pytlík, and M. Planková Up-regulation of p21WAF1 expression is mediated by Sp1/Sp3 transcription factors in TGFbeta1-arrested malignant B cells Med Sci Monit 12 2006 BR227 BR234
21. H.Q. Guo, W.Q. Wei, and N. Lu et al. [Liquid-based cytology for esophageal carcinoma screening] Ai Zheng 28 2009 1243 1247
22. X.H. Gao, Q.Z. Liu, and W. Chang et al. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray Cancer 119 2013 2212 2222
23. C.G. Peyre, J.A. Hagen, and S.R. DeMeester et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 2008 549 556
24. B.P. Wijnhoven, K.T. Tran, A. Esterman, D.I. Watson, and H.W. Tilanus An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus Ann Surg 245 2007 717 725